On these bases, we performed a retrospective analysis of a large cohort of patients (more than 140) with AOSD, to investigate the role of ferritin, ESR, and CRP, at the time of diagnosis, in predicting disease-related mortality and MAS occurrence, during the following prospective follow-up. The gene discussed is CRP; the disease is macrophage activation syndrome.